Pharmacological Treatment Of Depression In Late Life

Carl Salzman*, Lon S. Schneider, and George Alexopoulos
Harvard Medical School
Massachusetts Mental Health Center
74 Fenwood Road
Boston, Massachusetts  02115
Phone: (617) 232-1113
Fax: (617) 730-9748
E-Mail: carl_salzman@hms.harvard.edu



REFERENCES

1.   Abernethy DR, Greenblatt DJ, Shader RI. Imipramine and desipramine disposition in the elderly.  J Pharmacol Exp Ther 1985;232:183-188.

2.   Ackerman DL, Greenland S, Bystritsky, et al. Characteristics of fluoxetine versus placebo responders in a randomized trial of geriatric depression.  Psychopharmacol Bull 1997;33:707-714.

3.   Alexopoulos GS. The assessment and treatment of depressed-demented patients.  In: Nelson JC, ed. Geriatric Psychopharmacology. New York, N.Y.: Marcel Dekker, Inc., 1998:223-243.

4.   Alexopoulos GS, Salzman C. Treatment of depression with heterocyclic antidepressants, monoamine oxidase inhibitors, and psychomotor stimulants.  In: Clinical Geriatric Psychopharmacology, Third Edition. Baltimore, MD: Williams and Wilkins, 1998:184-244.

5.   Alexopoulos GS, Meyers BS, Young RC, et al. Clinically defined vascular depression.  Am J Psychiatry 1997;154:562-565.

6.   Alexopoulos G. Biological markers in geriatric depression. In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc., 1994

7.   Alexopoulos GS, Myers BS, Young RC, et al.  The course of geriatric depression with "reversible dementia": A controlled study.  Am J Psychiatry 1993;150:1693-1699.

8.   Alexopoulos GS, Chester JG. Outcomes of geriatric depression. Clinics in geriatric medicine 1992;8:363‑76.

9.   Alexopoulos GS, Young RC, Meyers BS, et al.  Late-onset depression.  Psychiatric Clinics of North America 1988;11:101-115.

10.  Baldwin RC.  Delusional and non-delusional depression in late life.  Evidence for distinct subtypes.  Br J of Psychiatry 1988;152:39-44.

11.  Blazer DG. Epidemiology of late-life depression.  In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff A, eds.  Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994, pp 9-19.

12.  Blazer D, Burchett B, Service C, et al.  The association of age in depression among the elderly: an epidemiologic exploration.  Journal of Gerontology 1991;46:M210-M215.

13.  Branconnier RJ, Cole JO, Ghazvinian S, Spera KF, Oxenkrug GF,  Bass JL.  Clinical pharmacology of bupropion and imipramine in elderly depressives.  J of Clin Psychiatry 1983;44(5, sec 2):130-133.

14.  Caine E, Lyness JM, King DA, Connor L. Clinical and diagnostic heterogeneity in depression in late life. In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.

15.  Conwell Y. Suicide in elderly patients.  In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994, pp 397-418.

16.  Dawling S, Crome P, Heyer EJ.  Nortriptyline therapy in elderly patients: Dosage prediction from plasma concentration at 24 hours after a single 50 mg dose.  Brit J Psychiat 1981;139:413-416.

17.  Dawling S.  Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers.  Clin Pharmacokinetics 1980;5:394-401.

18.  Devenand DP, Sano M, Tang M-X, et al.  Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.  Arch Gen Psychiatry 1996;53:175-182.

19.  Dietch JT.  The effect of nortriptyline in elderly patients with cardiac conduction disease.  J of Clin Psychiatry 1990;51:65-67.

20.  Furlanut M, and Benetello P.  The pharmacokinetics of tricyclic antidepressant drugs in the elderly.  Pharmacological Research 1990;22:15-25

21.  Gottfries CG. Scandinavian experience with citalopram in the elderly. Int Clin Psychopharmacol 1996;41(suppl 1):41-44.

22.  Hayes RL.  ECG findings in geriatric depressives given trazodone, placebo or imipramine.  J of Clin Psychiatry 1983;44:180-183.

23.  Jarvik LF, Read SL, Mintz J, Neshkes RE. Pretreatment orthostatic hypotension in geriatric depression: predictor of response to imipramine and doxepin. J Clin Psychopharmacol 1983;3:368-72.

24.  Kalayam B, Alexopoulos GS, Musiek FE, et al. Brainstorm evoked response abnormalities in late-life depression with vascular disease. Am J Psychiatry 1997;154:970-975.

25.  Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M.  Safety and efficacy of bupropion in elderly patients: preliminary observations.  J of Clin Psychiatry 1983;44(5, sec 2):134-136.

26.  Katz IR, Parmelee PA, Streim JE.  Depression in older patients in residential care.  Am J Geriatric Psychiatry 1995;3:161-169.

27.  Katz IR, Simpson GM, Curlik SM, Parmelee PA, Muhly C. Pharmacologic treatment of major depression for elderly patients in  residential care settings.  J Clin Psychiatry 990;51(suppl):41-47.

28.  Katz IR, Simpson GM, Jethanandani V, et al.  Steady state pharmacokinetics of nortriptyline in the frail elderly.  Neuropsychopharmacology 1989;2:229-236.

29.  Katz IR, Parmelee PA.  Depression in the residential care elderly.  In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.

30.  Kim KY.  Diagnosis and treatment of depression in the elderly.  Int'l J Psychiatry in Medicine 1988;18:211-221.

31.  Kitanaka I, Ross RJ, Cutler NR, et al.  Altered hydroxydesipramine concentrations in elderly depressed patients.  Clin Pharmacol Ther 1992;31:51-55.

32.  Klawansky S. Meta-analysis on the pharmacotherapeutic treatment of depression in late life.  In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life:  Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.

33.  Kocsis JH. Geriatric dysthymia.  J Clin Psychiatry 1998;59 (suppl 10):13-15.

34.  Krishnan KRR, Hays JC, and Blazer DG. MRI-defined vascular depression.  Am J Psychiatry 1997;154:497-501.

35.  Kumar A, Zhisong J, Bilker W, et al.  Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI.  Proc Natl Acad Scu USA 1998;95:7654-7658.

36.  Kumar A, Schweizer E, Zhizong J, et al.  Neuroanatomical substrates of late-life minor depression.  Arch Neurol 1997;54:613-617.

37.  Kumar V.  Plasma levels and effects of nortriptyline in geriatric depressed patients.  Acta Psychiatr Scand 1987;75:20-28.

38.  Kutcher SP, Shulman KI, Reed K. Desipramine plasma concentration and therapeutic response in elderly depressives: a naturalistic  pilot study. Can J of Psychiatry l986;31(8):752-4.

39.  McCue RE.  Plasma levels of nortriptyline and 10hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed.  J of Psychiatry Res 1989;23:73-79.

40.  McCue RE.  10-Hydroxynortriptyline and treatment effects in elderly depressed patients.  J of Neuropsych & Clin Neurosciences 1989;1:176-180.

41.  McCusker J, Cole M, Keller E, et al.  Effectiveness of treatments of depression in older ambulatory patients.  Arch Intern Med 1998;158:705-712.

42.  Mittmann N, Hermann N, Einarson TR, et al.  The efficacy, safety and tolerability of antidepressants in late life depression; a meta-analysis.  J Affect Disord 1997;46:191-217.

43.  Murphy E. The course and outcome of depression in late life.  In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life:  Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.

44.  Murphy E. The prognosis of depression in old age.  Br J of Psychiatry l983;142:111-119.

45.  Nelson JC. Treatment of major depression in the elderly.  In: Nelson JC, ed. Geriatric Psychopharmacology. New York, N.Y.: Marcel Dekker, Inc., 1998:61-97.

46.  Nelson JC, Atillasoy E, Mazure C, et al.  Hydroxydesipramine in the elderly.  J Clin Psychopharm 1988;8:428-433.

47.  Nelson JC, Jatlow PI, Mazure C. Desipramine plasma levels and response in elderly melancholic patients. J of Clin Psychopharmacol l985;5(4):217-20.

48.  Nies A, Robinson DS, Friedman MJ.  Relationship between age and tricyclic antidepressant plasma levels.  Am J Psychiatry 1977;134:790-793.

49.  Nobler MS, Devanand DP, Kim MK, et al. Fluoxetine treatment of dysthymia in the elderly.  J Clin Psychiatry 1996;57:254-256.

50.  Nyeth AL, Gottfries CG, Lyby K, at al.  A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without dementia.  Acta Psychiatr Scand 1992;86:138-145.

51.  Nyeth AL, Gottfries CG.  The clinical efficacy of citalopram in the treatment of emotional disturbances in dementia patients.  Br J Psychiatry 1990;157:894-901.

52.  Parmelee PA, Katz IR, Lawton MP.  Depression and mortality among institutionalized aged.  J Gerontology: Psychological Sciences 1992;47:P3-10.

53.  Pascualy M, Murburg MM, Veith RC. Cardiac risks of antidepressants in the elderly.  In: Shamoian CA, ed. Psychopharmacological Treatment Complications in the Elderly.  Washington: American Psychiatric Press, 1992.

54.  Peabody CA, Whiteford HA, Hollister LE.  Antidepressants and the elderly.  J Am Geriatrics Society 1986;34:869-874.

55.  Pfeiffer E, Baxter D, Candelora E, et al. Finding and treating depression in Alzheimer's patients: A study of the effects on patients and caregivers.  Psychopharmacol Bull 1997;33:721-729.

56.  Pickett P, Masand P, Murray GB. Psychostimulant treatment of geriatric depressive disorders secondary to medical illness.  J Geriatric Psychiatry and Neurol 1990;3(3):146-151.

57. Plotkin DA, Gerson SG, Jarvik LF. Antidepressant drug treatment in the elderly.  In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York: Raven Press, l987;114911-58.

58.  Pollock BG. Drug Interactions.  In: Nelson JC, ed. Geriatric Psychopharmacology. New York, N.Y.: Marcel Dekker, Inc., 1998:43-60.

59.  Pollock BG, Mulsant BH, Nebes R, et al. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline.  Am J Psychiatry 1998:155:1110-1112.

60.  Rapp SR, Parisi SA, Walsh DA.  Psychologicl dysfunction and physical health among elderly medical inpatients.  J Consulting Clin Psychology 1988;56:851-855.

61.  Reynolds CF, Schneider LS, Lebowitz BD, Kupfer DJ. Treatment of depression in the elderly: guidelines for primary care. In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life:  Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.

62.  Reynolds CF.  Treatment of depression in special populations.  J Clin Psychiatry 1992a;53:9(suppl):45-53.

63.  Reynolds CF, Frank E, Perel JM, et al. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. Amer J of Psychiatry 1992;149:1687-1692.

64.  Reynolds CF, Perel JM, Frank E, et al. Open-Trial Maintenance Pharmacotherapy in Late-Life Depression: Survival Analysis.  Psychiatry Res l989;27 225-31.

65.  Rockwell E, Lam RW, Zisook S.  Antidepressant drug studies in the elderly.  Psychiatric Clin N America 1988;11:215-233.

66.  Roose SP, and Suthers KM. Antidepressant response in late-life depression.  J Clin Psychiatry 1998;59 (suppl 10):4-8.

67.  Salzman C, (ed). Clinical Geriatric Psychopharmacology, Third Edition. Baltimore: Williams & Wilkins, 1998.

68.  Salzman C.  Monoamine oxidase inhibitors and atypical antidepressants.  Clinics in Geriatric Medicine 1992;8:335-348.

69.  Salzman C.  Antidepressants.  In: PF Lamy (ed).  Clinics in Geriatric Medicine.  Philadelphia, Saunders 1990:399-410.

70. Salzman C, Schneider L, Lebowitz B.  Antidepressant treatment of very old patients.  Am J Geriatric Psychiatry 1993;1:21-29.

71.  Salzman C.  Pharmacologic treatment of depression in the elderly.  J Clin Psychiatry 1993;54(supp):23-28.

72.  Salzman C. Pharmacological treatment of depression in the elderly.  In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life:  Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.

73.  Schneider LS, Small GW, Hamilton SH, et al. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial.  Am J Geriatric Psychiatry 1997;5:97-106.

74.  Schneider LS, Cooper TB, Severson JA.  Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.  J Clin Psychopharmacol 1988;8:402-408.

75.  Schneider LS, Sloane RB, Staples FR, Bender M. Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression. J Clin Psychopharmacol l986;6(3);172-176.

76.  Schneider LS, Cooper TB, Staples FR, et al.  Prediction of individual dosage of nortriptyline in depressed elderly outpatients.  J Clin Psychopharmacol 1987;7:311-314.

77.  Schneider LS, Reynolds CF, Lebowitz B, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Proceedings of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, 1994.

78.  Schneider LS. Comments on metaanalysis from a clinician's perspective.  In: Schneider LS, Reynolds CF, Lebowitz B, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Proceedings of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, 1994.

79.  Schneider LS.  Decreased platelet-3H-imipramine binding in primary major depression compared with depression secondary to medical illness in elderly oupatients.  J of Affective Disorders 1988;15:195-200.

80.  Shamoian CA, ed. Psychopharmacological Treatment Complications in the Elderly.  Washington, D.C.: American Psychiatric Press, 1992.

81.  Small GW, Salzman C. Treatment of depression with new and atypical antidepressants. In: Clinical Geriatric Psychopharmacology, Third Edition. Baltimore, MD: Williams and Wilkins, 1998:245-261.

82.  Snaith RP. Present use of the Hamilton Depression Rating Scale: observations on method of assessment in research of depressive disorders.  Br J Psychiatry 1996;168:594-597.

83.  Stack JA.  Pretreatment systolic orthostatic blood pressure (PSOP) and treatment response in elderly depressed inpatients.  J Clin Psychopharm 1988;8:116-120.

84.  Thapa PB, Gideon P, Cost TW, et al.  Antidepressants and the risk of falls among nursing home residents.  N Engl J Med 1998;339:875-882.

85.  Thayssen P.  Cardiovascular effects of imipramine and nortriptyline in elderly patients.  Psychopharmacology 1981;74:360-364.

86.  Veith RC, Raskind MA.  The neurobiology of aging:  does it predispose to depression?  Neurobiol Aging 1988;9:101-117

87.  von Moltke L, Greenblatt DJ, Shader RI.  Clinical pharmacokinetics of antidepressants in the elderly.  Clin Pharmacokinet 1993;24:141-160.

88.  Wiener P, Alexopoulos GS, Kakuma T, et al. The limits of history-taking in geriatric depression.  Am J Geriatric Psychiatry 1997;5:116-125.

89.  Wilkins JN.  Desipramine increased circulating growth hormone in elderly depressed patients: a pilot study.  Psychoneuroendocrin 1989;14:195-202.


Back to Chapter

published 2000